Oric Pharmaceuticals, Inc. SEC filings ORIC
Oric Pharmaceuticals, Inc. has 423 filings in SEC EDGAR's recent list, going back to Dec 13, 2019. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 3, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 23, 2026 | Oct 23, 2026 |
| 4 | Insider transaction | Oct 21, 2026 | Oct 20, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Oct 1, 2026 |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| 4 | Insider transaction | Sep 29, 2026 | Sep 28, 2026 |
| 4 | Insider transaction | Sep 25, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Aug 28, 2026 | Aug 26, 2026 |
| 144 | Notice of proposed sale | Aug 26, 2026 | — |
| 10-Q | Quarterly report | Aug 3, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| S-8 | Employee stock plan registration | Jul 30, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jul 30, 2026 | Jul 28, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 24, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 6, 2026 |
| 144 | Notice of proposed sale | Jul 6, 2026 | — |
| 144 | Notice of proposed sale | Jul 6, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2026 | — |
| 10-Q | Quarterly report | May 4, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 4, 2026 | May 4, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Other events
|
Mar 31, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Feb 26, 2026 | Feb 24, 2026 |
| 144 | Notice of proposed sale | Feb 24, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 23, 2026 | Feb 23, 2026 |
| 424B5 | Prospectus supplement | Feb 23, 2026 | — |
| S-8 | Employee stock plan registration | Feb 23, 2026 | — |
| 10-K | Annual report | Feb 23, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2026 | Feb 23, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 21, 2026 | — |
| 4 | Insider transaction | Jan 20, 2026 | Jan 16, 2026 |
| 144 | Notice of proposed sale | Jan 16, 2026 | — |
| 144 | Notice of proposed sale | Jan 16, 2026 | — |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 15, 2025 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 15, 2025 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 15, 2025 |
| 144 | Notice of proposed sale | Dec 16, 2025 | — |
| 144 | Notice of proposed sale | Dec 16, 2025 | — |
| 144 | Notice of proposed sale | Dec 16, 2025 | — |
| 4 | Insider transaction | Dec 9, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Other events
|
Dec 8, 2025 | Dec 6, 2025 |
| 4 | Insider transaction | Dec 5, 2025 | Dec 4, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 4 | Insider transaction | Oct 8, 2025 | Oct 6, 2025 |
| 4 | Insider transaction | Oct 8, 2025 | Oct 6, 2025 |
| 144 | Notice of proposed sale | Oct 6, 2025 | — |
| 4 | Insider transaction | Oct 3, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 144 | Notice of proposed sale | Sep 22, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs
|
Aug 12, 2025 | Aug 12, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 5, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 17, 2025 | — |
| 4 | Insider transaction | Jul 2, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 23, 2025 |
| 424B3 | Prospectus | Jun 24, 2025 | — |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| EFFECT | Filing | Jun 20, 2025 | — |
| CORRESP | Letter to the SEC | Jun 17, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 16, 2025 | — |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 10, 2025 |
| S-3 | Shelf registration | Jun 11, 2025 | — |
| 4 | Insider transaction | Jun 9, 2025 | Jun 6, 2025 |
| 144 | Notice of proposed sale | Jun 6, 2025 | — |
| D | Filing | Jun 6, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Jun 5, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 4, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 30, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
May 28, 2025 | May 23, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 5, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 5, 2025 | May 5, 2025 |
| ARS | Annual report to shareholders | Apr 23, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 23, 2025 | — |
| DEF 14A | Proxy statement | Apr 23, 2025 | Jun 11, 2025 |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Mar 14, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Other events
|
Feb 25, 2025 | Feb 25, 2025 |
| 10-K | Annual report | Feb 18, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 18, 2025 | Feb 18, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 15, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 15, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 15, 2024 |
| 144 | Notice of proposed sale | Dec 16, 2024 | — |
| 144 | Notice of proposed sale | Dec 16, 2024 | — |
| 144 | Notice of proposed sale | Dec 16, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | Jun 3, 2024 |
| 10-Q | Quarterly report | May 6, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 6, 2024 | May 6, 2024 |
| ARS | Annual report to shareholders | Apr 24, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| DEF 14A | Proxy statement | Apr 24, 2024 | Jun 12, 2024 |
| S-8 | Employee stock plan registration | Mar 29, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Mar 29, 2024 | Mar 26, 2024 |
| S-3ASR | Automatic shelf registration | Mar 11, 2024 | — |
| 10-K | Annual report | Mar 11, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2024 | Mar 11, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 11, 2024 | — |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 144 | Notice of proposed sale | Mar 6, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| 4 | Insider transaction | Feb 8, 2024 | Feb 6, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2024 | — |
| 144 | Notice of proposed sale | Feb 6, 2024 | — |
| EFFECT | Filing | Feb 2, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 1, 2024 | — |
| CORRESP | Letter to the SEC | Jan 31, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 30, 2024 | — |
| D | Filing | Jan 30, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 29, 2024 | — |
| S-3 | Shelf registration | Jan 26, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 25, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 22, 2024 | Jan 20, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2024 | Jan 9, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 2, 2024 |
| EFFECT | Filing | Dec 28, 2023 | — |
| CORRESP | Letter to the SEC | Dec 26, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2023 | — |
| 4 | Insider transaction | Dec 19, 2023 | Dec 15, 2023 |
| 4 | Insider transaction | Dec 19, 2023 | Dec 15, 2023 |
| 4 | Insider transaction | Dec 19, 2023 | Dec 15, 2023 |
| S-3 | Shelf registration | Dec 15, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 11, 2023 | Dec 11, 2023 |
| 10-Q | Quarterly report | Nov 6, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Other events
|
Oct 23, 2023 | Oct 21, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 4 | Insider transaction | Jul 11, 2023 | Jul 10, 2023 |
| 4 | Insider transaction | Jul 7, 2023 | Jul 5, 2023 |
| SC 13G | Ownership over 5% (passive) | Jul 7, 2023 | — |
| 144 | Notice of proposed sale | Jul 5, 2023 | — |
| D | Filing | Jul 5, 2023 | — |
| 4 | Insider transaction | Jun 28, 2023 | Jun 26, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jun 27, 2023 | Jun 24, 2023 |
| 144 | Notice of proposed sale | Jun 26, 2023 | — |
| 4 | Insider transaction | Jun 15, 2023 | Jun 14, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ORIC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1796280
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.